Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06181084 · ClinicalTrials.gov registry record · Phase 1
A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT06181084 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 60 participants.
The verdict
NCT06181084, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The main purpose of study is to compare different formulations of LY3410738 under fasting condition by looking at the amount of the study drug, LY3410738, that gets into the blood stream and how long it takes the body to get rid of it when given in healthy adult participants. The study will also access the effect of standard low-fat meal and esomeprazole (Proton Pump Inhibitor) on LY3410738. Safety and tolerability of LY3410738 will also be evaluated. For each participant, the total duration of the study will be 56 days for Groups 1 and 2 and up to 61 days for Groups 3 and 4, including screening.
Interventions
- DRUG Esomeprazole
- DRUG LY3410738
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2022-04-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06181084
The ClinicalTrials.gov registry entry for NCT06181084 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Esomeprazole is the first listed.
NCT06181084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06181084 about?
NCT06181084 is a clinical study titled "A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants". The main purpose of study is to compare different formulations of LY3410738 under fasting condition by looking at the amount of the study drug, LY3410738, that gets into the blood stream and how long it takes the body to get rid of it when given in healthy adult participants. The study will also acc...
What is the current status of trial NCT06181084?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2021-10-11. Estimated completion is 2022-04-28.
What interventions are being tested in trial NCT06181084?
The interventions under investigation include: Esomeprazole (DRUG), LY3410738 (DRUG).
Who is sponsoring clinical trial NCT06181084?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.